DOI: 10.1007/s00259-017-3892-0Pages: 1-2

177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?

1. University Hospital Muenster, Department of Nuclear Medicine

2. University Hospital Bonn, Department of Nuclear Medicine

3. University Hospital Muenster, Department of Urology

Correspondence to:
Kambiz Rahbar
Tel: +49-251-8347362
Email: rahbar@uni-muenster.de

Close

Abstract

To access the full text, please Sign in

If you have institutional access, please click here

  • Accepted: Nov 13, 2017
  • Online: Nov 21, 2017

Article Tools

eanm
EJNMMI Ad